Your Cart is Empty
BUY 1 GET 1 FREE · AUTO APPLIES AT CHECKOUT
Few questions generate more debate in wellness and public health circles than: is kratom an opioid? The answer is nuanced and critically important for anyone considering using kratom, particularly those with a history of substance use disorders or opioid dependence. Kratom occupies a unique pharmacological middle ground that makes simple classification difficult — but the facts are essential to understand.
Kratom (Mitragyna speciosa) is a plant from the coffee family (Rubiaceae) native to Southeast Asia. Its leaves have been used traditionally for centuries as a stimulant and analgesic. The plant's primary active alkaloids are mitragynine (~60–66% of total alkaloids) and 7-hydroxymitragynine (~2%), a metabolite that is significantly more potent at opioid receptors.
ExplorePureCraft CBD's kratom line for quality-tested products.
An opioid is any compound — natural, semi-synthetic, or synthetic — that acts on opioid receptors. The three primary types are:
Classical opioids — including morphine, oxycodone, fentanyl, and heroin — are potent, full agonists at mu-opioid receptors. Their defining characteristic is dose-dependent respiratory depression, which is the primary mechanism of opioid overdose deaths.
A landmark 2016 study in Journal of Medicinal Chemistry showed that mitragynine and its analogs are "G protein-biased" agonists at mu-opioid receptors — meaning they activate the receptor's G-protein pathway more selectively than the beta-arrestin pathway. This biased agonism is theoretically associated with less respiratory depression. However, this does not make kratom safe or free from opioid risks.
|
Feature |
Kratom |
Classical Opioids |
|
Receptor Activity |
Partial/biased agonist (mu); antagonist (kappa, delta) |
Full agonist (mu) |
|
Respiratory Depression Risk |
Lower (though not absent) |
High; primary overdose mechanism |
|
Origin |
Plant-derived (natural alkaloids) |
Natural, semi-synthetic, or synthetic |
|
Stimulant Properties |
Yes (at low doses) |
Rarely |
|
Dependence Risk |
Yes |
Yes (typically higher) |
|
Legal Status (US) |
Legal federally (in most states) |
Schedule I–IV controlled substances |
While kratom's biased agonism theoretically reduces respiratory depression risk, it does not eliminate it. Kratom-related fatalities have been reported — though the majority involve co-ingestion of other substances. The FDA has documented rare cases of kratom-only fatalities, often associated with high-dose extract products.
A major safety concern is product adulteration. Unregulated kratom products have been found to contain synthetic opioids, heavy metals, salmonella, and other contaminants. This underscores the critical importance of third-party testing — which all PureCraft CBD products undergo.
Kratom is metabolized by CYP450 liver enzymes, and it may inhibit these enzymes, affecting the metabolism of other drugs including antidepressants, anticoagulants, and other opioids. Combining kratom with respiratory depressants is particularly dangerous.
Kratom dependence is real and well-documented. Regular users who stop abruptly experience withdrawal symptoms including:
These symptoms strongly resemble opioid withdrawal — further evidence of kratom's opioid-like pharmacology. See our detailed article:Is Kratom Addictive?
The FDA has issued warning letters about kratom and attempted (unsuccessfully) to place it on the DEA's Schedule I controlled substances list. The DEA considered emergency scheduling in 2016 but withdrew after significant public and scientific pushback. As of 2024, kratom remains federally legal but unregulated as a dietary supplement.
Yes. Kratom's alkaloids, particularly 7-hydroxymitragynine, act on mu-opioid receptors — the same receptors activated by morphine and other classical opioids.
Some individuals report using kratom to ease opioid withdrawal, and this is an active area of research. However, this practice carries risks including kratom dependence and potentially dangerous interactions. It should only be done under medical supervision.
No. Kratom is not currently classified as a controlled substance at the federal level, though the FDA considers it a drug of concern and has taken enforcement actions against kratom vendors making medical claims.
The honest answer to "is kratom an opioid?" is: pharmacologically, partially — yes. Kratom's alkaloids interact with opioid receptors in ways that produce opioid-like effects and carry opioid-like risks including dependence, withdrawal, and rare overdose potential. However, kratom's unique biased agonism, multi-receptor activity, and stimulant properties at low doses distinguish it meaningfully from classical opioids.
PureCraft CBD is committed to transparency. View ourlab results (COAs) for all kratom products.
Kratom's legal status is one of the most frequently asked questions surrounding this popular botanical. The answer is genuinely complicated: kratom...
Read More
Kratom (Mitragyna speciosa) has become one of the most debated botanical products in the American wellness market. Millions of people use it regula...
Read More
One of the most common questions from people considering kratom for the first time is simply: what does it feel like? The challenge is that kratom'...
Read More